Squarepoint’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$678K Buy
36,215
+14,135
+64% +$265K ﹤0.01% 1736
2025
Q1
$397K Sell
22,080
-41,336
-65% -$744K ﹤0.01% 2038
2024
Q4
$1.07M Buy
63,416
+18,159
+40% +$305K ﹤0.01% 1493
2024
Q3
$732K Sell
45,257
-35,653
-44% -$577K ﹤0.01% 1583
2024
Q2
$665K Buy
80,910
+21,078
+35% +$173K ﹤0.01% 1583
2024
Q1
$886K Buy
59,832
+27,453
+85% +$406K ﹤0.01% 1411
2023
Q4
$469K Buy
+32,379
New +$469K ﹤0.01% 1734
2023
Q3
Sell
-1,993
Closed -$25.7K 2789
2023
Q2
$25.7K Buy
+1,993
New +$25.7K ﹤0.01% 2327
2023
Q1
Sell
-2,801
Closed -$42K 2695
2022
Q4
$42K Sell
2,801
-53,881
-95% -$808K ﹤0.01% 2159
2022
Q3
$669K Buy
+56,682
New +$669K ﹤0.01% 1275
2022
Q2
Sell
-1,764
Closed -$53K 2543
2022
Q1
$53K Sell
1,764
-13,518
-88% -$406K ﹤0.01% 2102
2021
Q4
$405K Sell
15,282
-18,674
-55% -$495K ﹤0.01% 1722
2021
Q3
$1.23M Buy
33,956
+7,805
+30% +$283K ﹤0.01% 992
2021
Q2
$1.14M Buy
26,151
+16,237
+164% +$705K ﹤0.01% 1108
2021
Q1
$339K Buy
+9,914
New +$339K ﹤0.01% 1802
2020
Q4
Sell
-22,385
Closed -$537K 2821
2020
Q3
$537K Sell
22,385
-14,249
-39% -$342K 0.01% 1301
2020
Q2
$670K Buy
36,634
+24,048
+191% +$440K 0.01% 1137
2020
Q1
$196K Sell
12,586
-49,280
-80% -$767K 0.01% 1478
2019
Q4
$1.32M Sell
61,866
-48,381
-44% -$1.04M 0.01% 1138
2019
Q3
$2.06M Buy
110,247
+59,851
+119% +$1.12M 0.02% 814
2019
Q2
$1.32M Buy
50,396
+16,025
+47% +$418K 0.01% 1084
2019
Q1
$883K Buy
34,371
+32,754
+2,026% +$841K 0.01% 1161
2018
Q4
$37K Sell
1,617
-3,042
-65% -$69.6K ﹤0.01% 1840
2018
Q3
$150K Sell
4,659
-4,323
-48% -$139K ﹤0.01% 1823
2018
Q2
$254K Buy
+8,982
New +$254K ﹤0.01% 1451
2017
Q4
Sell
-1,294
Closed -$33K 2291
2017
Q3
$33K Buy
+1,294
New +$33K ﹤0.01% 1558
2017
Q2
Sell
-2,939
Closed -$97K 1751
2017
Q1
$97K Sell
2,939
-5,731
-66% -$189K ﹤0.01% 1408
2016
Q4
$206K Buy
+8,670
New +$206K 0.01% 1424